Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.93% | 158.00 | 0.0% | $686.24m | |
| AMGN | Amgen, Inc. | -0.25% | 250.58 | 1.5% | $604.45m | |
| GILD | Gilead Sciences, Inc. | -0.47% | 66.02 | 1.0% | $437.82m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.24% | 299.23 | 1.9% | $414.73m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.91% | 636.34 | 2.6% | $364.61m | |
| ILMN | Illumina, Inc. | -3.10% | 213.02 | 3.3% | $317.77m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.98% | 4.06 | 0.7% | $283.81m | |
| NVAX | Novavax, Inc. | -8.19% | 39.37 | 75.7% | $258.88m | |
| BIIB | Biogen, Inc. | -0.94% | 217.58 | 1.8% | $192.12m | |
| BNTX | BioNTech SE | -5.19% | 152.04 | 0.0% | $149.19m | |
| GOVX | GeoVax Labs, Inc. | 0.44% | 2.26 | 0.0% | $119.92m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.20% | 94.84 | 4.2% | $100.34m | |
| SAVA | Cassava Sciences, Inc. | 27.26% | 25.72 | 0.0% | $95.08m | |
| CRSP | CRISPR Therapeutics AG | -5.42% | 71.74 | 0.6% | $92.05m | |
| PACB | Pacific Biosciences of California, Inc. | -4.88% | 7.61 | 6.2% | $87.70m |
Company Profile
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.